Table 2.
Reported Cases with Legionnaires’ Disease-associated Fanconi Syndrome.
| Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | |
|---|---|---|---|---|---|
| Age/Gender | 75/M | 57/M | 65/M | 63/M | 70/M |
| Treatment | PZFX, GRNX | PZFX, LVFX, GRNX | AZM | LVFX | AZM, LVFX |
| Blood test | |||||
| Urea nitrogen (mg/dL) | 17 | 41 | 14 | 11 | 13 |
| Creatinine (mg/dL) | 0.88 | 2.23 | 0.85 | 0.75 | 1.05 |
| Uric acid (mg/dL) | 2.4 | 2.7 | 3.8 | 1.4 | 2.1 |
| Sodium (mEq/L) | 121 | 143 | 128 | 128 | 128 |
| Potassium (mEq/L) | 3.4 | 3.5 | 3.6 | 3.3 | 3.9 |
| Chloride (mEq/L) | 83 | 107 | 91 | 93 | 93 |
| Phosphorus (mg/dL) | 1.3 | 2 | 1.5 | 1.2 | 1.9 |
| Creatine phosphokinase (IU/L) | 670 | 2,330 | 2,999 | 12,675 | 8,611 |
| Urinalysis | |||||
| Protein | 2+ | 2+ | 2+ | 2+ | 2+ |
| Glucose | 3+ | 2+ | 2+ | + | 1+ |
| Aminoaciduria | + | + | + | + | + |
| %TRP | 54 | 51 | 47.9 | 81.1 | 69 |
| FEUA | 18.7 | 42.8 | 11.7 | 18.6 | 15.5 |
| β2-microglobulin (μg/L) | 80,397 | 110,556 | 67,900 | 115,000 | 83,326 |
| NAG (U/L) | 18 | 19.7 | 51.2 | 22.9 | 58.1 |
| Reference | (5) | (5) | (6) | (6) | Present case |
AZM: azithromycin, FEUA: fractional excretion of uric acid, GRNX: garenoxacin, LVFX: levofloxacin, NAG: N-acetyl-β-D-glucosaminidase, PZFX: pazufloxacin, %TRP: tubular reabsorption of phosphate